Management of cancer patients + imaging LC Flashcards
Malignancy prediction of cutaneous and subcutaneous neoplasms in canines using B-mode ultrasonography, Doppler, and ARFI elastography
Malignancy was associated with non deformable tissue and shear wave velocity > 3.52m/s
verified association between Heterogeneous echotexture, invasiveness, hyperechoic spots, cavity areas with malignancy
Effect of slice thickness on computed tomographic perfusion analysis of the pancreas in healthy dog
Results supported that a thin slice thickness of 2.4 mm can be used for assessment of pancreatic perfusion variables in healthy dogs
Use of computed tomography and radiation therapy planning software to develop a novel formula for body surface area calculation in dogs
Contoured BSA differed from the current formula by −9% to +19%.
Nonlinear regression on untransformed data yielded BSA = 0.0134 × body weight [kg]∧0.4746 × length (cm)∧0.6393 as the best-fit model.
Metastatic diagnosis of canine sternal lymph nodes using computed tomography characteristics
Size (StLN-to-second sternebraratio [ratio-size]) and precontrast attenuation achieved a specificity and positive predictive value of 100% of identifying metastasis to sternal LN
Staging canine patients with appendicular osteosarcoma utilizing fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography compared to whole body computed tomography
Comparing F-FDG PET/CT to whole body CT 13 osseous lesions concerning for mets were identified on PET/CT that would have been missed and 4 comordid neoplastic conditions
F-FDG PET/CT is more efficacious than whole body CT for staging
what is the anitdote to mustargen extravasation
sodium thiosulfate
vesicant
Pilot study to evaluate the efficacy of lymphotropic nanoparticle enhanced MRI for diagnosis of metastatic disease in canine head and neck tumours
LNMRI has the potential to be a sensitive and specific method of diagnosing lymph node metastasis
LNMRI utilizes ultra-small superparamagnetic iron oxide nanoparticles (USPIOs) to help in the detection of metastatic disease in lymph nodes. USPIOs are phagocytized and localized to normal lymph nodes where they assist in evaluation for regions of effacement by cancerous cells.
Loperamide (Imodium)
MOA and tox
acts on opioid receptors in the gastrointestinal tract, slowing intestinal motility and reducing fluid secretion
operamide can cause central nervous system depression, manifested by sedation, ataxia, and respiratory depression, especially at high doses.
Cats are more sensitive to loperamide toxicity, and even small doses can lead to severe symptoms such as bradycardia, hypothermia, and respiratory depression.
Overdose can be life-threatening and requires immediate veterinary attention
Kaolin-Pectin - mech /tox
Kaolin absorbs water and toxins in the gastrointestinal tract
safe
Metronidazole (Flagyl)- mech/tox
Side effects can include gastrointestinal upset, nausea, vomiting, and in rare cases, neurotoxicity (e.g., ataxia, seizures) at high doses or with prolonged use.
Metronidazole should be used cautiously in animals with liver disease.
mech - disrupts protein and dna synthesis Bacteroides spp.
Clostridium spp.
Fusobacterium spp.
Peptostreptococcus spp.
canalevia- Crofelemer
normalizes the hypersecretion of both the cyclic adenosine monophosphate (cAMP)-stimulated cystic fibrosis transmembrane conductance regulator (CFTR) chloride (Cl ) channel and the calcium-activated Cl channel (CaCC) at the luminal membrane of intestinal enterocytes. Disregulation of the CFTR and CaCC channels increases the osmotic gradient and causes excessive fluid influx into the lumen, resulting in secretory diarrhea.
capromorelin mech
binds to ghrelin receptor stimulates the release of growth hormone (GH) from the pituitary gland and enhances appetite.
diarrhea, vomiting, polydipsia, hypersalivation, flatulence, nausea, abdominal discomfort, increased gut sounds, and lethargy.20 Elevated BUN and phosphorus have also been noted
may cause bradycardia transiently in cats
cerenia mech/tox
neurokinin-1 (NK-1) receptor antagonist that acts in the emetic center within the CNS by inhibiting the binding of substance P, which is the key neurotransmitter involved in vomiting.
can cause prolongation of the QT interval because of cardiac potassium channel blockade
caution in hepatic failure - met in liver
ondansetron mech/tox
5-HT3 receptor antagonist. 5-HT3 receptors are found peripherally on vagal nerve terminals and centrally in the chemoreceptor trigger zone (CRTZ)
GI effects (eg, constipation, diarrhea), sedation, extrapyramidal clinical signs (eg, head shaking), increased liver enzymes, arrhythmias, and hypotension can be possible
humans get headaches
mirtaz mech/tox
potent inhibitor of the 5-HT2, 5-HT3, and histamine (H1) receptors. Antagonism at 5-HT3 receptors accounts for the antinausea and antiemetic effects of the drug, and its action at H1 receptors produces prominent sedative effects. It is a moderate peripheral α1-adrenergic antagonist, a property that may explain the occasional orthostatic hypotension
antidepressant activity of mirtazapine appears to be mediated by antagonism at central presynaptic alpha-2
were vocalization (56%), agitation (31%), vomiting (26.2%), abnormal gait/ataxia (16.7%), restlessness (14.3%), tremors/trembling (14.3%), hypersalivation (13%), tachypnea (11.9%), tachycardia (10.7%), and lethargy